Financials

  • Market Capitalization 3.16 B
  • Employee 370
  • Founded 2016
  • CEO N/A
  • Website www.tarsusrx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RB9BNQ7
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-51.5
Relación precio/flujo de caja
7.58

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1686
CLDX
Celldex Therapeutics, Inc. - Common Stock
40.46 USD-0.27%+0.20%+13.72%+48.53%3.18 B USD
1688
IRON
Disc Medicine, Inc. - Common Stock
82.55 USD-0.15%+3.84%+10.86%+37.93%3.17 B USD
1695
BEAM
Beam Therapeutics Inc. - Common Stock
30.48 USD+0.96%+6.05%+16.38%+80.68%3.15 B USD
1701
ARQT
Arcutis Biotherapeutics, Inc. - Common stock
24.87 USD-1.07%-2.43%-11.84%+60.14%3.13 B USD

Noticias